Reply

Hannah S J Choi^{1

2}, Willem P Brouwer³, Bettina E Hansen^{1

3

4}, Harry L A Janssen¹, Keyur Patel¹

Affiliations

¹ Toronto Centre for Liver Disease, University Health Network, Toronto, ON, Canada.
² Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
³ Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
⁴ Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.

Comment

Hannah S J Choi et al. Hepatology. 2020 Feb.

. 2020 Feb;71(2):769.

doi: 10.1002/hep.30980. Epub 2020 Jan 28.

Hannah S J Choi^{1

2}, Willem P Brouwer³, Bettina E Hansen^{1

3

4}, Harry L A Janssen¹, Keyur Patel¹

¹ Toronto Centre for Liver Disease, University Health Network, Toronto, ON, Canada.
² Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
³ Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
⁴ Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.

No abstract available

Comment on

Nonalcoholic Steatohepatitis Is Associated With Liver-Related Outcomes and All-Cause Mortality in Chronic Hepatitis B.
Choi HSJ, Brouwer WP, Zanjir WMR, de Man RA, Feld JJ, Hansen BE, Janssen HLA, Patel K. Choi HSJ, et al. Hepatology. 2020 Feb;71(2):539-548. doi: 10.1002/hep.30857. Epub 2019 Oct 17. Hepatology. 2020. PMID: 31309589
Letter to the Editor: Impact of Nonalcoholic Steatohepatitis on Liver-Related Outcomes in Chronic Hepatitis B.
Huang R, Wang J, Zhang Z, Yan X, Wu C. Huang R, et al. Hepatology. 2020 Feb;71(2):767. doi: 10.1002/hep.30981. Epub 2020 Jan 24. Hepatology. 2020. PMID: 31587343 No abstract available.
Letter to the Editor: Chronic Hepatitis B and Nonalcoholic Steatohepatitis: Is "Fat" All Bad?
Li J, Cheung RC, Nguyen MH. Li J, et al. Hepatology. 2020 Feb;71(2):768. doi: 10.1002/hep.30983. Epub 2020 Jan 26. Hepatology. 2020. PMID: 31595532 No abstract available.

1. Kim SU, Seo YS, Lee HA, Kim MN, Lee YR, Lee HW, et al. A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in South Korea. J Hepatol 2019;71:456-464.
1. Flemming JA, Terrault NA. Tenofovir vs entecavir for hepatocellular carcinoma prevention in patients with chronic hepatitis B: one of these things is not like the other. JAMA Oncol 2019;5:17-18.